[1]
“Plasmapheresis Combined with First-Line mFOLFOX-6 and Bevacizumab Therapy in Metastatic Colorectal Cancer”, Вопр. онкол., vol. 71, no. 4, p. OF-2396, Sep. 2025, doi: 10.37469/0507-3758-2025-71-4-OF-2396.